Peptime operates an openly browsable catalog. An independent analysis by PeptideBenchmark identified that 5 of 15 reviewed Peptime products link to exact Freedom Diagnostics reports that resolve on the laboratory's own server-controlled report host - meaning the COAs are independently verifiable through Freedom Diagnostics' own system, not just hosted copies on the vendor's site. The five confirmed reports average 99.7% stated purity and include HPLC, identity, and net-content results. Freedom Diagnostics is the same lab used by Verified Peptides (80/100), Ion Peptides (78/100), and Alpha Omega Peptides (64/100) in this catalog. The score is constrained by partial catalog coverage - only one-third of reviewed products had confirmed lab linkages at time of analysis - and a very short operational track record. No operating entity, physical address, or individual names are publicly disclosed on the site.
| Dimension | Max | Notes | Score |
|---|---|---|---|
| Third-Party Testing Practice | 30 | Freedom Diagnostics (Tennessee) confirmed as testing lab on at least 5 products via PeptideBenchmark independent analysis. Freedom Diagnostics reports on these products resolve on the lab's own server-controlled host, providing an independently verifiable path. Average reported purity 99.7% across confirmed reports. HPLC, identity, and net-content results included. Freedom Diagnostics is a publicly verifiable US lab with an independent archive of 15,000+ COAs. Deduction for partial catalog coverage: confirmed lab linkage on approximately one-third of reviewed products, with the remaining two-thirds unconfirmed from available public sources at time of scoring. | 19/30 |
| Batch Traceability & Verification | 20 | Freedom Diagnostics reports that resolve on the lab's own servers provide genuine batch-to-lab traceability for the 5 confirmed products. Because Freedom Diagnostics maintains its own independent public archive, these reports can be verified through a source the vendor does not control. Deduction for the approximately two-thirds of the reviewed catalog without confirmed provider-linked documentation at time of analysis. | 12/20 |
| COA Accessibility | 15 | The catalog is openly browsable at peptime.com. Product pages link to Freedom Diagnostics reports that resolve on Freedom's own server-controlled host for the confirmed products. This is publicly accessible pre-purchase verification without login - the same access model that earns high accessibility scores from Verified Peptides and Ion Peptides. Deduction for partial catalog coverage: confirmed accessible COAs on approximately one-third of reviewed products. | 10/15 |
| COA Completeness | 15 | Freedom Diagnostics methodology covers HPLC purity, mass spectrometry identity, and net-content analysis. PeptideBenchmark confirms these three elements on the five verified Peptime reports. Freedom Diagnostics' standard service does not include sterility or endotoxin panels as confirmed on other Freedom-tested vendors in this catalog. Scope consistent with Freedom's standard service. | 8/15 |
| Testing Recency | 10 | Vendor estimated to have launched 2025-2026. Five Trustpilot reviews at time of scoring suggests very recent operation. All confirmed COAs would be recent. No evidence of stale documentation; the Freedom Diagnostics reports resolve on current servers. Credit for a new vendor with confirmed recent testing on available products. | 5/10 |
| Policy Transparency | 5 | A refund policy page exists at /refund-policy/ (accessible per search-indexed content). US-based positioning stated. No operating entity name, physical address, phone number, or individual names publicly identified from available sources. PeptideBenchmark independently audited and confirmed the Freedom Diagnostics lab linkages, providing external validation of the testing claims. Partial credit for the US positioning claim, refund policy existence, and the PeptideBenchmark external validation. | 2/5 |
| Operational Track Record | 5 | Estimated 2025-2026 launch. Five Trustpilot reviews at time of scoring - a very limited review volume. No entity name, no registration information, no named founders publicly disclosed. Very new operation; insufficient track record to carry meaningful weight. | 1/5 |
| Total | 57/100 |